Skip to content
ppharmaranks
Menu

Best treatments for vasculogenic impotence

7 products may treat vasculogenic impotence, spanning FDA drug classes such as phosphodiesterase 5 inhibitor. The current highest-rated option is vybrique. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 7 drugs we list for vasculogenic impotence, all are available as lower-cost generics, spanning classes such as phosphodiesterase 5 inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for vasculogenic impotence — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Get treated for vasculogenic impotence online

Licensed online providers — consult & get prescribed if eligible.

Advertising disclosure: We may earn a commission, at no extra cost to you. This never affects our ratings. Details

Top-rated picks for vasculogenic impotence: 1. Vybrique · 2. Adcirca · 3. Revatio

Top-rated treatments for vasculogenic impotence, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100$0View →
270/100$4View →
370/100$0View →
470/100$0View →
556/100$4View →
6Not yet rated$4View →
7Not yet rated$4View →

Full ranking · 7 treatments

#1 of 6 in Phosphodiesterase 5 Inhibitor

vybrique

PrescriptionFDA-sourced

72/100

Vybrique (Sildenafil Citrate) is a phosphodiesterase 5 inhibitor used to treat Pulmonary Hypertension, Vasculogenic Impotence.

(8 data points)
phosphodiesterase 5 inhibitorhypertension, pulmonaryimpotence, vasculogenic

Pharmacy pays

From ~$0.05· 5 forms
View details →
#2 of 6 in Phosphodiesterase 5 Inhibitor

adcirca

PrescriptionFDA-sourced

70/100

Adcirca (Tadalafil) is a phosphodiesterase 5 inhibitor used to treat Pulmonary Hypertension, Vasculogenic Impotence.

(3 data points)
phosphodiesterase 5 inhibitorhypertension, pulmonaryimpotence, vasculogenic

Pharmacy pays

From ~$3.13/30· 4 forms
View details →
VIATRIS logo
#2 of 6 in Phosphodiesterase 5 Inhibitor

revatio

PrescriptionFDA-sourced

70/100

Revatio (Sildenafil Citrate) is a phosphodiesterase 5 inhibitor used to treat Pulmonary Hypertension, Vasculogenic Impotence.

(11 data points)
phosphodiesterase 5 inhibitorhypertension, pulmonaryimpotence, vasculogenic

Pharmacy pays

From ~$0.05· 5 forms
View details →
VIATRIS logo
#2 of 6 in Phosphodiesterase 5 Inhibitor

viagra

PrescriptionFDA-sourced

70/100

Viagra (Sildenafil Citrate) is a phosphodiesterase 5 inhibitor used to treat Pulmonary Hypertension, Vasculogenic Impotence.

(11 data points)
phosphodiesterase 5 inhibitorhypertension, pulmonaryimpotence, vasculogenic

Pharmacy pays

From ~$0.05· 5 forms
View details →

alyq

PrescriptionFDA-sourced

56/100

Alyq (Tadalafil) is a phosphodiesterase 5 inhibitor used to treat Pulmonary Hypertension, Vasculogenic Impotence.

(124 data points)
phosphodiesterase 5 inhibitorhypertension, pulmonaryimpotence, vasculogenic

Pharmacy pays

From ~$3.13/30· 4 forms
View details →

cialis

PrescriptionFDA-sourced

New

Cialis (Tadalafil) is a phosphodiesterase 5 inhibitor used to treat Pulmonary Hypertension, Vasculogenic Impotence.

phosphodiesterase 5 inhibitorhypertension, pulmonaryimpotence, vasculogenic

Pharmacy pays

From ~$3.13/30· 4 forms
View details →

Frequently asked

What treats vasculogenic impotence?
Our catalog lists 7 products that may treat vasculogenic impotence, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is vybrique.
What is the best-rated treatment for vasculogenic impotence?
By our independent recall-safety rating — not an efficacy measure — vybrique ranks highest among the products we list for vasculogenic impotence. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat vasculogenic impotence?
Treatments for vasculogenic impotence span FDA drug classes including phosphodiesterase 5 inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.